Antifungal agents and the kidney: pharmacokinetics, clinical nephrotoxicity, and interactions
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antifungal agents and the kidney: pharmacokinetics, clinical nephrotoxicity, and interactions
Authors
Keywords
-
Journal
Expert Opinion On Drug Safety
Volume -, Issue -, Pages -
Publisher
Informa UK Limited
Online
2021-04-24
DOI
10.1080/14740338.2021.1922667
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antifungal Therapy: New and Evolving Therapies
- (2020) Yasmine Nivoix et al. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
- Pharmacokinetics and safety of posaconazole intravenous solution and powder for oral suspension in children with neutropenia: an open-label, sequential dose-escalation trial
- (2020) Andreas H. Groll et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- An Overview of the Management of the Most Important Invasive Fungal Infections in Patients with Blood Malignancies
- (2020) Aref Shariati et al. Infection and Drug Resistance
- Posaconazole Serum Drug Levels Associated with Pseudohyperaldosteronism
- (2019) Minh-Vu H Nguyen et al. CLINICAL INFECTIOUS DISEASES
- Adverse effects of amphotericin B in children; a retrospective comparison of conventional and liposomal formulations
- (2018) Eden C. Andrew et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- COMPARATIVE EFFECTIVENESS AND SAFETY BETWEEN AMPHOTERICIN B LIPID-FORMULATIONS: A SYSTEMATIC REVIEW
- (2018) Luiza Raquel Grazziotin et al. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE
- Isavuconazole: A new broad-spectrum azole. Part 1: In vitro activity
- (2018) J. Denis et al. JOURNAL DE MYCOLOGIE MEDICALE
- Tolerability profile of the current antifungal armoury
- (2018) Ahmad Mourad et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- OUP accepted manuscript
- (2018) MEDICAL MYCOLOGY
- Isavuconazole for treatment of rare invasive fungal diseases
- (2018) Oliver A. Cornely et al. MYCOSES
- Successful treatment of invasive mucormycosis with isavuconazole in pediatric patients
- (2018) Assaf A. Barg et al. PEDIATRIC BLOOD & CANCER
- Efficacy and Safety of Echinocandins for the Treatment of Invasive Candidiasis in Children
- (2018) Magdalini Tsekoura et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Fungal infections in hematopoietic stem cell transplantation in children at a pediatric children’s hospital in Argentina
- (2018) Sergio M. Gomez et al. Transplant Infectious Disease
- Invasive candidiasis
- (2018) Peter G. Pappas et al. Nature Reviews Disease Primers
- Candidemia due to uncommon Candida species in children: new threat and impacts on outcomes
- (2018) Ming-Horng Tsai et al. Scientific Reports
- OUP accepted manuscript
- (2018) Journal of the Pediatric Infectious Diseases Society
- Isavuconazole and voriconazole for the treatment of chronic pulmonary aspergillosis: A retrospective comparison of rates of adverse events
- (2018) Felix Bongomin et al. MYCOSES
- Isavuconazole Kinetic Exploration for Clinical Practice
- (2018) Léa Darnaud et al. Drugs in research & development
- Successful outcome of disseminated mucormycosis in a 3-year-old child suffering from acute leukaemia: the role of isavuconazole? A case report
- (2018) Marjorie Cornu et al. BMC Pharmacology & Toxicology
- Phase I trial to investigate the effect of renal impairment on isavuconazole pharmacokinetics
- (2017) Robert W. Townsend et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients
- (2017) Romuald Bellmann et al. INFECTION
- Efficacy and safety of amphotericin B formulations: a network meta-analysis and a multicriteria decision analysis
- (2017) Fernanda S. Tonin et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Antifungal Drugs in Newborns and Children
- (2017) Mihai Puia-Dumitrescu et al. PEDIATRIC CLINICS OF NORTH AMERICA
- Drug-drug interactions between triazole antifungal agents used to treat invasive aspergillosis and immunosuppressants metabolized by cytochrome P450 3A4
- (2017) Andreas H. Groll et al. Transplant Infectious Disease
- Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species
- (2017) Sarah G. Whaley et al. Frontiers in Microbiology
- Antifungal Agents
- (2016) Jeniel E. Nett et al. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- Adverse Drug Reactions in Patients Receiving Systemic Antifungal Therapy at a High-Complexity Hospital
- (2016) Maria Clara Padovani de Souza et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial
- (2016) Johan A Maertens et al. LANCET
- Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis
- (2016) Francisco M Marty et al. LANCET INFECTIOUS DISEASES
- Therapeutic drug monitoring and safety of intravenous voriconazole formulated with sulfobutylether β-cyclodextrin in haematological patients with renal impairment
- (2016) Si-Hyun Kim et al. MYCOSES
- Efficacy and safety of amphotericin B lipid-based formulations-A systematic review and meta-analysis
- (2016) Laiza M. Steimbach et al. MYCOSES
- Role of isavuconazole in the treatment of invasive fungal infections
- (2016) Dustin Wilson et al. Therapeutics and Clinical Risk Management
- Isavuconazole for the treatment of invasive aspergillosis and mucormycosis: current evidence, safety, efficacy, and clinical recommendations
- (2016) Suganthini Krishnan Natesan et al. Infection and Drug Resistance
- Incidence, Predictors, and Impact on Hospital Mortality of Amphotericin B Nephrotoxicity Defined Using Newer Acute Kidney Injury Diagnostic Criteria
- (2015) Paulo Novis Rocha et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A double-blinded, placebo-controlled, multicenter clinical trial ofN-acetylcysteine for preventing amphotericin B-induced nephrotoxicity
- (2015) Iman Karimzadeh et al. Expert Opinion on Drug Metabolism & Toxicology
- Hematological toxicities associated with amphotericin B formulations
- (2015) Diego R. Falci et al. LEUKEMIA & LYMPHOMA
- Comparison of nephrotoxicity associated to different lipid formulations of amphotericin B: a real-life study
- (2015) Diego R. Falci et al. MYCOSES
- Alopecia and Nail Changes Associated With Voriconazole Therapy
- (2014) A. N. Malani et al. CLINICAL INFECTIOUS DISEASES
- Tissue Penetration of Antifungal Agents
- (2014) T. Felton et al. CLINICAL MICROBIOLOGY REVIEWS
- Voriconazole Metabolism, Toxicity, and the Effect of Cytochrome P450 2C19 Genotype
- (2014) Dimitrios Zonios et al. JOURNAL OF INFECTIOUS DISEASES
- Drug-Induced Nephrotoxicity: Clinical Impact and Preclinical in Vitro Models
- (2014) Ho Yee Tiong et al. MOLECULAR PHARMACEUTICS
- Prospective Phase II Single-Center Study of the Safety of a Single Very High Dose of Liposomal Amphotericin B for Antifungal Prophylaxis in Patients with Acute Myeloid Leukemia
- (2013) Luciana Annino et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Voriconazole-Associated Cutaneous Malignancy: A Literature Review on Photocarcinogenesis in Organ Transplant Recipients
- (2013) K. Williams et al. CLINICAL INFECTIOUS DISEASES
- Nephrotoxicity and other adverse events among inpatients receiving liposomal amphotericin B or amphotericin B lipid complex
- (2013) Rolin L. Wade et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Amphotericin B Formulations: A Comparative Review of Efficacy and Toxicity
- (2013) Richard J. Hamill DRUGS
- Alteration in cellular viability, pro-inflammatory cytokines and nitric oxide production in nephrotoxicity generation by Amphotericin B: involvement of PKA pathway signaling
- (2013) F. D. França et al. JOURNAL OF APPLIED TOXICOLOGY
- Administration of Voriconazole in Patients With Renal Dysfunction
- (2012) D. Neofytos et al. CLINICAL INFECTIOUS DISEASES
- Does Lipid Emulsion Reduce Amphotericin B Nephrotoxicity? A Systematic Review and Meta-analysis
- (2012) S. Mistro et al. CLINICAL INFECTIOUS DISEASES
- Changes in Incidence and Antifungal Drug Resistance in Candidemia: Results From Population-Based Laboratory Surveillance in Atlanta and Baltimore, 2008-2011
- (2012) A. A. Cleveland et al. CLINICAL INFECTIOUS DISEASES
- Liposomal amphotericin B does not induce nephrotoxicity or renal function impairment in premature neonates
- (2012) P. Manzoni et al. EARLY HUMAN DEVELOPMENT
- Detection and management of nephrotoxicity during drug development
- (2012) Dr Mahmoud Loghman-Adham et al. Expert Opinion On Drug Safety
- Risk Factors of Amphotericin B Toxicty in the Nonneonatal Pediatric Population
- (2012) Ankhi Dutta et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Safety analysis of liposomal amphotericin B in adult patients: anaemia, thrombocytopenia, nephrotoxicity, hepatotoxicity and hypokalaemia
- (2011) Akari Shigemi et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Randomized Comparison of Safety and Pharmacokinetics of Caspofungin, Liposomal Amphotericin B, and the Combination of Both in Allogeneic Hematopoietic Stem Cell Recipients
- (2010) A. H. Groll et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Systematic Review and Meta-Analysis of the Tolerability and Hepatotoxicity of Antifungals in Empirical and Definitive Therapy for Invasive Fungal Infection
- (2010) J. L. Wang et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Therapy for fungal diseases: opportunities and priorities
- (2010) David W. Denning et al. TRENDS IN MICROBIOLOGY
- Chronic phototoxicity and aggressive squamous cell carcinoma of the skin in children and adults during treatment with voriconazole
- (2009) Edward W. Cowen et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- SAFETY EXPERIENCE WITH CASPOFUNGIN IN PEDIATRIC PATIENTS
- (2009) Theoklis Zaoutis et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Amphotericin B: side effects and toxicity
- (2009) Rafael Laniado-Laborín et al. REVISTA IBEROAMERICANA DE MICOLOGIA
- Amphotericin B lipid complex versus liposomal amphotericin B monotherapy for invasive aspergillosis in patients with hematologic malignancy
- (2008) Ray Y. Hachem et al. CANCER
- Pharmacokinetics, Safety and Tolerance of Voriconazole in Renally??Impaired Subjects
- (2008) Samantha Abel et al. CLINICAL DRUG INVESTIGATION
- Hallucinations during Voriconazole Therapy
- (2008) Dimitrios I. Zonios et al. CLINICAL INFECTIOUS DISEASES
- Isavuconazole: a new and promising antifungal triazole for the treatment of invasive fungal infections
- (2008) Jesús Guinea et al. Future Microbiology
- Treatment of invasive fungal infections in clinical practice: a multi-centre survey on customary dosing, treatment indications, efficacy and safety of voriconazole
- (2008) Jörg J. Vehreschild et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Renal impairment and Amphotericin B formulations in patients with invasive fungal infections
- (2008) Faouzi Saliba et al. MEDICAL MYCOLOGY
- The clinical and pharmacoeconomic analysis of invasive aspergillosis in adult patients with haematological diseases
- (2008) A. Atahan Cagatay et al. MYCOSES
- Influence of sodium intake on Amphotericin B-induced nephrotoxicity among extremely premature infants
- (2008) Rodica Turcu et al. PEDIATRIC NEPHROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started